Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Raw Materials (2016 - 2025)

Innospec (IOSP) has disclosed Raw Materials for 16 consecutive years, with $103.0 million as the latest value for Q4 2025.

  • Quarterly Raw Materials changed 0.1% to $103.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103.0 million through Dec 2025, changed 0.1% year-over-year, with the annual reading at $103.0 million for FY2025, 0.1% changed from the prior year.
  • Raw Materials hit $103.0 million in Q4 2025 for Innospec, down from $108.9 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $114.9 million in Q3 2022 to a low of $64.6 million in Q1 2021.
  • Historically, Raw Materials has averaged $97.8 million across 5 years, with a median of $101.5 million in 2022.
  • Biggest five-year swings in Raw Materials: skyrocketed 56.97% in 2022 and later fell 25.83% in 2023.
  • Year by year, Raw Materials stood at $89.3 million in 2021, then grew by 27.44% to $113.8 million in 2022, then dropped by 25.83% to $84.4 million in 2023, then rose by 22.16% to $103.1 million in 2024, then dropped by 0.1% to $103.0 million in 2025.
  • Business Quant data shows Raw Materials for IOSP at $103.0 million in Q4 2025, $108.9 million in Q3 2025, and $101.6 million in Q2 2025.